ArticleFrontiers in immunology2026

Predictors of subsequent relapse-independent progression after high-efficacy therapy in relapsing multiple sclerosis.

Matteo Foschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.